APA (7th ed.) Citation

WX, X., YM, Y., JL, C., XY, G., C, L., J, L., . . . X, C. (2025). SPP1+ tumor-associated macrophages define a high-risk subgroup and inform personalized therapy in hepatocellular carcinoma. Frontiers in oncology, 15, 1606195. https://doi.org/10.3389/fonc.2025.1606195

Chicago Style (17th ed.) Citation

WX, Xu, Ye YM, Chen JL, Guo XY, Li C, Luo J, Lu LB, and Chen X. "SPP1+ Tumor-associated Macrophages Define a High-risk Subgroup and Inform Personalized Therapy in Hepatocellular Carcinoma." Frontiers in Oncology 15 (2025): 1606195. https://doi.org/10.3389/fonc.2025.1606195.

MLA (9th ed.) Citation

WX, Xu, et al. "SPP1+ Tumor-associated Macrophages Define a High-risk Subgroup and Inform Personalized Therapy in Hepatocellular Carcinoma." Frontiers in Oncology, vol. 15, 2025, p. 1606195, https://doi.org/10.3389/fonc.2025.1606195.